Geneyx Genomex

AI-based Genetic Data Analysis Platform

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in July 2018 by David Yizhar, Raviv Itzhaky, and Ofer Barnea, Geneyx Genomex operates with 11–50 employees. The company has raised a total of $14 million across eight funding rounds from four investors. In March 2024, Children's Mercy Kansas City and Geneyx Inc. announced a collaboration to advance genomic research and analysis.

Business overview

Geneyx Genomex is dedicated to integrating comprehensive genomic insights into healthcare and pharmaceutical research through its sophisticated AI-based data analysis platform. The company's core technology provides secondary and tertiary analysis of germline and somatic sequencing data, aiming to improve diagnostic yields and turnaround times. Geneyx serves a diverse client base including hospitals, genetics labs, and life-science companies, operating within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Digital Medical Diagnostics, and Medical Decision Support.

Strategic signal

In September 2024, Geneyx Genomex was selected as one of three Israeli startups to participate in Google’s new AI First accelerator program. This selection signals strong validation of Geneyx's AI-driven approach to genetic data analysis and its potential for significant innovation within the health tech sector, attracting further attention from major technology players and investors.

Company Intelligence Q&A

What is Geneyx Genomex's primary focus?
Geneyx Genomex focuses on transforming the integration of genomics into healthcare and pharmaceutical research with its AI-based genetic data analysis platform.
When was Geneyx Genomex founded and by whom?
Geneyx Genomex was founded in July 2018 by David Yizhar, Raviv Itzhaky, and Ofer Barnea.
What was a significant recent collaboration for Geneyx Genomex?
In March 2024, Children's Mercy Kansas City and Geneyx Inc. announced a collaboration to advance genomic research and analysis.
Which accelerator program did Geneyx Genomex join recently?
In September 2024, Geneyx Genomex was selected as part of Google’s new AI First accelerator program.
Did Geneyx Genomex make any acquisitions?
In October 2020, Geneyx Genomex acquired NGS sequencing analysis firm Toldot Genetics.

External links